Young-Shin Lee
ORCID: 0000-0003-2381-8019
· 1 paper in corpus
article
2018
Abstract Background Improvement of cytopenia is one of the primary treatment purposes for patients with the lower-risk myelodysplastic syndrome (MDS). Androgens have been used for the treatment of aplastic anemia, immune thrombocytopenia, a…